company background image
HPIC logo

Hayat Pharmaceutical Industries ASE:HPIC Stock Report

Last Price

د.أ2.49

Market Cap

د.أ23.7m

7D

-0.4%

1Y

-19.9%

Updated

16 Jun, 2024

Data

Company Financials

Hayat Pharmaceutical Industries Co. PLC

ASE:HPIC Stock Report

Market Cap: د.أ23.7m

HPIC Stock Overview

Engages in the manufacture and marketing of generic pharmaceutical products in Jordan.

HPIC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends2/6

Hayat Pharmaceutical Industries Co. PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hayat Pharmaceutical Industries
Historical stock prices
Current Share Priceد.أ2.49
52 Week Highد.أ3.11
52 Week Lowد.أ2.40
Beta0.20
1 Month Change-0.80%
3 Month Change-3.49%
1 Year Change-19.94%
3 Year Change-32.15%
5 Year Change31.05%
Change since IPO33.16%

Recent News & Updates

Recent updates

Shareholder Returns

HPICJO PharmaceuticalsJO Market
7D-0.4%-1.0%-0.9%
1Y-19.9%1.5%-5.2%

Return vs Industry: HPIC underperformed the JO Pharmaceuticals industry which returned 1.5% over the past year.

Return vs Market: HPIC underperformed the JO Market which returned -5.2% over the past year.

Price Volatility

Is HPIC's price volatile compared to industry and market?
HPIC volatility
HPIC Average Weekly Movement2.1%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement3.7%
10% most volatile stocks in JO Market6.0%
10% least volatile stocks in JO Market2.3%

Stable Share Price: HPIC has not had significant price volatility in the past 3 months.

Volatility Over Time: HPIC's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994236Maher Mohammed Al Kurdiwww.hayatpharma.com

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

Hayat Pharmaceutical Industries Co. PLC Fundamentals Summary

How do Hayat Pharmaceutical Industries's earnings and revenue compare to its market cap?
HPIC fundamental statistics
Market capد.أ23.66m
Earnings (TTM)د.أ2.45m
Revenue (TTM)د.أ15.11m

9.6x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HPIC income statement (TTM)
Revenueد.أ15.11m
Cost of Revenueد.أ5.90m
Gross Profitد.أ9.20m
Other Expensesد.أ6.75m
Earningsد.أ2.45m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.26
Gross Margin60.93%
Net Profit Margin16.24%
Debt/Equity Ratio7.0%

How did HPIC perform over the long term?

See historical performance and comparison

Dividends

6.6%

Current Dividend Yield

66%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.